Torthaí cuardaigh - Rohit Loomba

Beachtaigh na torthaí
  1. 1
    Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions

    Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions de réir Rohit Loomba

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers

    Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers de réir Mazen Noureddin, Rohit Loomba

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH

    The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH de réir Rohit Loomba, Naga Chalasani

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease

    Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease de réir Amir Zarrinpar, Rohit Loomba

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions

    Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions de réir Rohit Loomba, T. Jake Liang

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications

    Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications de réir Saumya Jayakumar, Rohit Loomba

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality

    PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality de réir Stefan Stender, Rohit Loomba

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Imaging biomarkers of NAFLD, NASH, and fibrosis

    Imaging biomarkers of NAFLD, NASH, and fibrosis de réir Veeral Ajmera, Rohit Loomba

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Advances in the genetics of nonalcoholic fatty liver disease

    Advances in the genetics of nonalcoholic fatty liver disease de réir Veeral Ajmera, Rohit Loomba

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

    Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis de réir Erin K. Spengler, Rohit Loomba

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD

    Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD de réir Elliot B. Tapper, Rohit Loomba

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH

    The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH de réir Rohit Loomba, Leon A. Adams

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Advances in non-invasive assessment of hepatic fibrosis

    Advances in non-invasive assessment of hepatic fibrosis de réir Rohit Loomba, Leon A. Adams

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC

    Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC de réir Suzanne R. Sharpton, Rohit Loomba

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Targeting Dysbiosis for the Treatment of Liver Disease

    Targeting Dysbiosis for the Treatment of Liver Disease de réir Gobind Anand, Amir Zarrinpar, Rohit Loomba

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

    Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease de réir Michelle T. Long, Sanil Gandhi, Rohit Loomba

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk

    The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk de réir Cyrielle Caussy, Adrien Aubin, Rohit Loomba

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD

    Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD de réir Nobuharu Tamaki, Veeral Ajmera, Rohit Loomba

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease

    Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease de réir Rohit Loomba, Vincent Wai‐Sun Wong

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study

    Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study de réir Rohit Loomba, Ricki Bettencourt, E. Barrett-Connor

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: